Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.410.370.350.370.31

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.41 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.41
Mar20240.37
Mar20230.35
Mar20220.37
Mar20210.31

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.41
10.81
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37
19.35
Mar2021 0.31 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,611.1 Cr -7% -6.1% -22.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,032.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹183,759.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,224.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹116,214.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹108,739.0 Cr 0.7% 5.5% 9.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-7%

-6.1%

-22.4%

SENSEX

-3.1%

-2.8%

-6.1%


You may also like the below Video Courses